Early exposure to interleukin-21 limits rapidly generated anti–Epstein-Barr virus T-cell line differentiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early exposure to interleukin-21 limits rapidly generated anti–Epstein-Barr virus T-cell line differentiation

Published:2015-04 Issue:4 Volume:17 Page:496-508
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Orio Julie,Carli Cédric,Janelle Valérie,Giroux Martin,Taillefer Julie,Goupil Mathieu,Richaud Manon,Roy Denis-Claude,Delisle Jean-Sébastien

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference51 articles.

1. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients;Heslop;Blood,2010

2. T-cell therapy in the treatment of post-transplant lymphoproliferative disease;Bollard;Nat Rev Clin Oncol,2012

3. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins;Bollard;J Clin Oncol,2014

4. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation;Doubrovina;Blood,2012

5. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma;Bollard;Cytotherapy,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy;Molecular Therapy - Methods & Clinical Development;2022-12

2. Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use;Cytotherapy;2022-03

3. Combined PD-L1 and TIM-3 blockade improves the expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy;2021-09-02

4. Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy;Journal of Biological Engineering;2021-04-13

5. T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies;Cancers;2021-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3